These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 23990016

  • 21. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
    Zhang YQ, Wei XL, Liang YK, Chen WL, Zhang F, Bai JW, Qiu SQ, Du CW, Huang WH, Zhang GJ.
    PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469
    [Abstract] [Full Text] [Related]

  • 22. Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.
    Fujii R, Imanishi Y, Shibata K, Sakai N, Sakamoto K, Shigetomi S, Habu N, Otsuka K, Sato Y, Watanabe Y, Ozawa H, Tomita T, Kameyama K, Fujii M, Ogawa K.
    J Exp Clin Cancer Res; 2014 May 10; 33(1):40. PubMed ID: 24887090
    [Abstract] [Full Text] [Related]

  • 23. Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma.
    Wangmo C, Charoen N, Jantharapattana K, Dechaphunkul A, Thongsuksai P.
    Pathol Oncol Res; 2020 Jul 10; 26(3):1511-1518. PubMed ID: 31471883
    [Abstract] [Full Text] [Related]

  • 24. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.
    van Nes JG, de Kruijf EM, Putter H, Faratian D, Munro A, Campbell F, Smit VT, Liefers GJ, Kuppen PJ, van de Velde CJ, Bartlett JM.
    Breast Cancer Res Treat; 2012 May 10; 133(1):49-59. PubMed ID: 21796367
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ, Yu WN, Kuo SC, Ho CT, Hung CM, Way TD, Chen CT.
    J Cell Physiol; 2019 Jun 10; 234(6):9118-9129. PubMed ID: 30341909
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Correlation of Twist and YB-1 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma].
    Li M, Guan H, Hu X, Wang Y, Wei Q, Yang Q.
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug 10; 44(8):594-9. PubMed ID: 26705185
    [Abstract] [Full Text] [Related]

  • 29. Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins.
    Liu PF, Kang BH, Wu YM, Sun JH, Yen LM, Fu TY, Lin YC, Liou HH, Lin YS, Sie HC, Hsieh IC, Tseng YK, Shu CW, Hsieh YD, Ger LP.
    PLoS One; 2017 Aug 10; 12(6):e0178581. PubMed ID: 28570699
    [Abstract] [Full Text] [Related]

  • 30. Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival.
    Kong YH, Syed Zanaruddin SN, Lau SH, Ramanathan A, Kallarakkal TG, Vincent-Chong VK, Wan Mustafa WM, Abraham MT, Abdul Rahman ZA, Zain RB, Cheong SC.
    PLoS One; 2015 Aug 10; 10(7):e0134045. PubMed ID: 26214683
    [Abstract] [Full Text] [Related]

  • 31. P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.
    Lo Muzio L, Pannone G, Mignogna MD, Staibano S, Mariggiò MA, Rubini C, Procaccini M, Dolci M, Bufo P, De Rosa G, Piattelli A.
    Histol Histopathol; 2004 Oct 10; 19(4):1089-99. PubMed ID: 15375751
    [Abstract] [Full Text] [Related]

  • 32. A Correlative Study of N-Cadherin Expression with Different Grades of Oral Squamous Cell Carcinoma Projecting as a Marker of Epithelial to Mesenchymal Transition in Tumor Progression.
    Rai K H, Ahmed J.
    Asian Pac J Cancer Prev; 2019 Aug 01; 20(8):2327-2332. PubMed ID: 31450902
    [Abstract] [Full Text] [Related]

  • 33. The expressions and prognostic implications of Twist and E-cadherin in adenocarcinomas of the gastroesophageal junction and proximal gastric carcinoma.
    Sun S, Gong Q.
    Medicine (Baltimore); 2019 Dec 01; 98(52):e18449. PubMed ID: 31876727
    [Abstract] [Full Text] [Related]

  • 34. E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis.
    de Freitas Silva BS, Yamamoto-Silva FP, Pontes HA, Pinto Júnior Ddos S.
    J Oral Pathol Med; 2014 Feb 01; 43(2):125-31. PubMed ID: 23772858
    [Abstract] [Full Text] [Related]

  • 35. Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma.
    Ota K, Fujimori H, Ueda M, Jono H, Shinriki S, Ota T, Sueyoshi T, Taura M, Taguma A, Kai H, Shinohara M, Ando Y.
    Int J Oncol; 2010 Oct 01; 37(4):797-804. PubMed ID: 20811700
    [Abstract] [Full Text] [Related]

  • 36. Over-expression of integrin-linked kinase correlates with aberrant expression of Snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis.
    Zhao D, Tang XF, Yang K, Liu JY, Ma XR.
    Clin Exp Metastasis; 2012 Dec 01; 29(8):957-69. PubMed ID: 22638656
    [Abstract] [Full Text] [Related]

  • 37. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
    Lo Muzio L, Campisi G, Farina A, Rubini C, Pannone G, Serpico R, Laino G, De Lillo A, Carinci F.
    BMC Cancer; 2005 Jun 21; 5():63. PubMed ID: 15967043
    [Abstract] [Full Text] [Related]

  • 38. Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients.
    Xie F, Li K, Ouyang X.
    Clin Exp Metastasis; 2009 Jun 21; 26(8):1025-32. PubMed ID: 19816777
    [Abstract] [Full Text] [Related]

  • 39. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.
    Shiogama S, Yoshiba S, Soga D, Motohashi H, Shintani S.
    Anticancer Res; 2013 Oct 21; 33(10):4309-17. PubMed ID: 24122997
    [Abstract] [Full Text] [Related]

  • 40. Changed expression of E-cadherin and galectin-9 in oral squamous cell carcinomas but lack of potential as prognostic markers.
    Chan SW, Kallarakkal TG, Abraham MT.
    Asian Pac J Cancer Prev; 2014 Oct 21; 15(5):2145-52. PubMed ID: 24716948
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.